NWSA vs SGMT · rev $9.03B vs $403.2M cap
NWSA (NWSA) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
NWSA (NWSA) common stock.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
SGMT does not have a complete income-statement cache yet.
NWSA currently screens at market cap $0. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the NWSA and SGMT stock pages for the full models.
Not investment advice.